Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 3125 of 3173 entries
View as:

A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03343054 Org: User:
Start: 11/30/17 End: 07/18/24 Due: 07/18/25

Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01730339 Org: User:
Start: 12/31/12 End: 10/31/14 Due: 10/31/15

This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data.

Phase: N/A Priority: Normal
NCT ID: NCT05082428 Org: User:
Start: 05/30/22 End: 11/01/22 Due: 11/01/23

12 Week Evaluation of the Safety and Efficacy of a Flexible Dose of CP-526,555 and Placebo for Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT00150228 Org: User:
Start: 12/31/01 End: 09/30/02 Due: 09/30/03

This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.

Phase: N/A Priority: Normal
NCT ID: NCT05858450 Org: User:
Start: 05/05/23 End: 05/12/23 Due: 05/12/24

Study to Evaluate the Effect of Repeat-Dose Rifampin on the Pharmacokinetics (PK) of PF-06651600

Phase: N/A Priority: Normal
NCT ID: NCT04266509 Org: User:
Start: 06/25/20 End: 09/10/20 Due: 09/10/21

A Study to Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System

Phase: N/A Priority: Normal
NCT ID: NCT05438602 Org: User:
Start: 08/03/22 End: 11/13/23 Due: 11/13/24

Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00650455 Org: User:
Start: 02/28/03 End: 01/31/05 Due: 01/31/06

Study in Healthy Adults Evaluating PF-07202954

Phase: N/A Priority: Normal
NCT ID: NCT04857437 Org: User:
Start: 05/13/21 End: 09/17/21 Due: 09/17/22

Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers.

Phase: N/A Priority: Normal
NCT ID: NCT02534935 Org: User:
Start: 08/31/15 End: 03/17/20 Due: 03/17/21

A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis

Phase: N/A Priority: Normal
NCT ID: NCT01298531 Org: User:
Start: 05/31/11 End: 04/30/13 Due: 04/30/14

A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03356977 Org: User:
Start: 01/16/18 End: 04/12/19 Due: 04/12/20

Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03334851 Org: User:
Start: 11/17/17 End: 02/15/22 Due: 02/15/23

Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule

Phase: N/A Priority: Normal
NCT ID: NCT00460486 Org: User:
Start: 09/30/06 End: - Due: -

Assessment of the Analgesic Effects of PF-05089771 and Pregabalin in Healthy Volunteers Using Evoked Pain Endpoints

Phase: N/A Priority: Normal
NCT ID: NCT02349607 Org: User:
Start: 01/31/15 End: 03/31/15 Due: 03/31/16

NeisVac-C Single Prime Study in Infants

Phase: N/A Priority: Normal
NCT ID: NCT01218451 Org: User:
Start: 09/30/10 End: 06/30/12 Due: 06/30/13

A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.

Phase: N/A Priority: Normal
NCT ID: NCT00163111 Org: User:
Start: 09/30/98 End: 05/31/03 Due: 05/31/04

Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00965731 Org: User:
Start: 01/31/10 End: 01/31/14 Due: 01/31/15

A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)

Phase: N/A Priority: Normal
NCT ID: NCT03448692 Org: User:
Start: 10/15/18 End: 02/14/23 Due: 02/14/24

A Study to Learn About the Safety of PREVENAR 20 Vaccine in Infants Aged Between Two to Six Months

Phase: N/A Priority: Normal
NCT ID: NCT06622109 Org: User:
Start: 11/25/24 End: 03/24/27 Due: 03/24/28

A Study to Learn About the Drug-drug Interactions of Sisunatovir in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT03782662 Org: User:
Start: 11/07/18 End: 03/17/19 Due: 03/17/20

A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01781572 Org: User:
Start: 06/30/13 End: 02/20/18 Due: 02/20/19

Assessment Of The Effects Of Single Doses Of An Investigational Drug, Given Alone Or With Donepezil, On Scopolamine-Induced Changes In Memory And Learning In Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01345864 Org: User:
Start: 05/31/11 End: 08/31/11 Due: 08/31/12

A Single, High-Dose Azithromycin Extended Release (60 mg/kg) Compared With 10 Days of High-Dose Amoxicillin Clavulanate in Children With Ear Infections at High Risk of Persistent/Recurrent Ear Infections

Phase: N/A Priority: Normal
NCT ID: NCT00643292 Org: User:
Start: 01/31/03 End: 05/31/04 Due: 05/31/05

Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00494091 Org: User:
Start: 02/28/07 End: 03/31/12 Due: 03/31/13